Zhou, Sirui
Butler-Laporte, Guillaume http://orcid.org/0000-0001-5388-0396
Nakanishi, Tomoko http://orcid.org/0000-0001-9510-5646
Morrison, David R. http://orcid.org/0000-0001-8380-3615
Afilalo, Jonathan
Afilalo, Marc
Laurent, Laetitia
Pietzner, Maik
Kerrison, Nicola
Zhao, Kaiqiong
Brunet-Ratnasingham, Elsa http://orcid.org/0000-0002-3613-1315
Henry, Danielle
Kimchi, Nofar
Afrasiabi, Zaman http://orcid.org/0000-0003-4395-5168
Rezk, Nardin http://orcid.org/0000-0001-5358-7704
Bouab, Meriem
Petitjean, Louis http://orcid.org/0000-0002-9223-5100
Guzman, Charlotte http://orcid.org/0000-0002-2979-4436
Xue, Xiaoqing
Tselios, Chris
Vulesevic, Branka
Adeleye, Olumide
Abdullah, Tala
Almamlouk, Noor
Chen, Yiheng
Chassé, Michaël
Durand, Madeleine
Paterson, Clare
Normark, Johan
Frithiof, Robert http://orcid.org/0000-0003-2278-7951
Lipcsey, Miklós
Hultström, Michael http://orcid.org/0000-0003-4675-1099
Greenwood, Celia M. T. http://orcid.org/0000-0002-2427-5696
Zeberg, Hugo
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Thysell, Elin
Pollak, Michael
Mooser, Vincent
Forgetta, Vincenzo
Kaufmann, Daniel E. http://orcid.org/0000-0003-4467-136X
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Article History
Received: 11 October 2020
Accepted: 5 February 2021
First Online: 25 February 2021
Ethics declarations
: All institutions contributing cohorts to the COVID-19 Host Genetics Initiative received ethics approval from their respective research ethics review boards. This study was approved by the research ethics boards of the Jewish General Hospital and the Centre Hospitalier du Université de Montréal. Informed consent was obtained from the participants of BQC19.
: J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. C.P. is an employee of SomaLogic. M.P. has consulted for Astellas Pharma, Ansh Labs, Immunomet, Zymeworks and Pfizer on unrelated projects. All other authors declare that there are no conflicts of interest.
Free to read: This content has been made available to all.